SELLAS Life Sciences Group, Inc. (SLS) Price
SELLAS Life Sciences Group, Inc.
SLS
Los datos de mercado no están disponibles.
Volumen (24 h)
--
Oferta en circulación
--
Capitalización de mercado
--
Acerca de SELLAS Life Sciences Group, Inc. (SLS)
Acerca de SELLAS Life Sciences Group, Inc. (SLS)
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company focused on developing novel cancer immunotherapies. Its lead asset, galinpepimut-S, targets a range of cancers including acute myeloid leukemia and mesothelioma. SELLAS operates in a highly specialized field with strong scientific backing and multiple ongoing trials. It aims to deliver targeted, life-extending treatments to patients with unmet medical needs.
Descarga la
Aplicación móvil de Gemini
Recomienda a tus amigos y gana criptomonedas.
Invita a tus amigos a Gemini y ambos ganarán $50 en criptomonedas cuando tu referido opere $100 en sus primeros 30 días.
Tokens en tendencia
Tokens en tendencia
Gemini ActiveTrader®
Opera SELLAS Life Sciences Group, Inc. en la plataforma diseñada y construida para operadores
Tokens en tendencia
Tokens en tendencia
Acerca de SELLAS Life Sciences Group, Inc. (SLS)
Acerca de SELLAS Life Sciences Group, Inc. (SLS)
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company focused on developing novel cancer immunotherapies. Its lead asset, galinpepimut-S, targets a range of cancers including acute myeloid leukemia and mesothelioma. SELLAS operates in a highly specialized field with strong scientific backing and multiple ongoing trials. It aims to deliver targeted, life-extending treatments to patients with unmet medical needs.